Infant Phototherapy Device Market Trends & Summary

The global infant phototherapy device market is entering a new phase of innovation and steady expansion, driven by rising neonatal jaundice cases, growing awareness of infant health, and rapid advancements in medical device technology. According to Renub Research, the market—valued at US$ 99.95 million in 2024—is projected to reach US$ 140.92 million by 2033, registering a CAGR of 3.89% between 2025 and 2033. From improved LED-based systems to expanded neonatal care infrastructure, the field is progressing to meet the demands of a world welcoming nearly 130 million newborns each year.

As neonatal jaundice remains one of the most common health conditions in newborns, phototherapy continues to serve as an essential treatment to prevent serious complications such as kernicterus and long-term neurological damage. The increasing emphasis on early diagnosis, advanced treatment methods, and accessible neonatal care forms the foundation of growth within the global market.

Download Free Sample Report

Understanding the Infant Phototherapy Market

Infant phototherapy is a specialized treatment used to lower bilirubin levels in newborns diagnosed with neonatal jaundice. When bilirubin levels rise excessively—due to the immaturity of a newborn’s liver—exposure to specific wavelengths of blue or green light transforms bilirubin into a soluble form that can be excreted naturally. This simple yet life-saving mechanism makes phototherapy a staple in neonatal care units worldwide.

A significant portion of the market's evolution comes from modern LED phototherapy devices, which offer greater efficiency, reduced heat output, and longer operational lifespans compared to traditional lighting systems. These technologies have made treatment safer and more precise, supporting improved clinical outcomes in high-risk newborns.

Market Growth Drivers

1. Rising Prevalence of Neonatal Jaundice

Neonatal jaundice affects more than half of full-term newborns and nearly 80% of preterm infants. As awareness grows regarding the dangers of untreated jaundice, healthcare facilities worldwide are prioritizing screening and early intervention. This has directly translated into increased adoption of phototherapy devices.

Countries with high birth rates—such as India, China, and regions in Africa—see significant demand for neonatal jaundice treatment. For instance, China’s shift from its one-child policy has influenced birth rates considerably. According to the National Bureau of Statistics, the country recorded 9.02 million births in 2023, emphasizing the ongoing need for neonatal care technologies. As populations continue to grow, demand for phototherapy devices is expected to rise proportionately.

2. Technological Advancements in Phototherapy Devices

The shift toward LED-based phototherapy is one of the most transformative trends in the market. LEDs offer consistent and efficient light output, reduced energy consumption, and minimal heat emission—making them ideal for prolonged treatment sessions.

In November 2024, NeoLight achieved a significant milestone when its Skylife Neonatal Phototherapy System received a Breakthrough Technology group purchasing agreement from Premier, Inc. This agreement allows thousands of U.S. hospitals under the Premier network to access advanced phototherapy equipment at reduced prices, accelerating adoption across the country.

Innovations such as portable devices, foldable light units, and home-based phototherapy systems are also broadening market potential, especially in rural or resource-limited settings.

3. Increased Investment in Neonatal Healthcare

Governments, NGOs, and private healthcare providers are increasingly prioritizing neonatal health outcomes. Investments in NICUs, maternal health campaigns, and improved diagnostic tools aim to reduce infant mortality, especially in emerging economies.

In February 2024, the Paediatric Neuroimaging Group released an educational animation series to help parents understand premature infants’ breathing and neurological challenges. While not directly linked to phototherapy, such initiatives highlight the growing ecosystem focused on neonatal care—an environment that encourages adoption of advanced treatment devices like phototherapy systems.

Challenges in the Infant Phototherapy Device Market

1. High Cost of Phototherapy Devices

Advanced LED-based phototherapy units, while more efficient, remain costly. Facilities in low-income regions often rely on older fluorescent lamp-based systems due to budget constraints. The cost of maintenance, replacement bulbs, and training further complicates widespread adoption. This challenge is especially significant in countries with underfunded healthcare systems.

2. Limited Access in Rural Settings

Rural hospitals and clinics often lack the necessary infrastructure for phototherapy treatment. Uneven distribution of healthcare resources, shortage of trained personnel, and logistical difficulties hinder timely care for newborns.

Addressing these disparities requires systemic improvements—mobile health units, portable phototherapy devices, and government-led infrastructure programs targeted at rural populations.

Market Breakdown by Light Source

Fluorescent Lamps

Fluorescent lamps have served as the standard phototherapy option for decades due to their affordability. They effectively emit light in the blue spectrum necessary for bilirubin breakdown. However, their shorter lifespan, greater heat production, and higher energy consumption make them less desirable compared to LEDs. Still, they remain in use across cost-sensitive markets where upgrading to LED models is financially challenging.

Quartz Halogen Lamps

Quartz halogen lamps offer intense light but generate significant heat, posing potential risks of thermal injury to fragile newborns. As a result, their use is declining, especially in developed markets where safety standards are higher and LED alternatives are readily accessible.

LED Phototherapy Devices

LED systems have become the preferred choice globally due to their superior efficiency, minimal heat output, long lifespan, and wavelength precision. Their growing adoption significantly contributes to market expansion.

Market Breakdown by Configuration

Mobile Devices

Mobile phototherapy devices have gained notable traction, especially in home care settings and rural regions. Their portability gives them an edge in hospitals with high patient turnover or limited NICU space. These devices enable effective treatment outside traditional hospital environments, making them invaluable for outreach healthcare programs.

Fixed Devices

Fixed phototherapy units remain dominant in hospitals and neonatal care centers globally. Their larger treatment areas, higher intensity output, and advanced monitoring capabilities make them indispensable in NICUs handling complex cases.

End-User Insights

Hospitals

Hospitals continue to hold the largest market share, driven by the high number of newborns requiring phototherapy treatment. Improvements in neonatal care protocols and increased investment in NICUs ensure consistent demand for advanced phototherapy systems.

Neonatal Clinics

Neonatal clinics are expanding rapidly, especially in urban regions. Their specialized focus on newborn health and treatment of jaundice makes them significant contributors to market growth. These clinics often invest in the latest phototherapy units to ensure high-quality outcomes.

Regional Market Highlights

United States

The United States leads the global infant phototherapy device market due to its highly advanced healthcare infrastructure and high awareness of neonatal conditions. Adoption of innovative technologies remains high, supported by the presence of key players and ongoing R&D initiatives.

NeoLight’s 2024 agreement with Premier, Inc. reinforces the U.S. position as a hub for neonatal innovation and sets the stage for expanded device adoption through better pricing and industry recognition.

France

France exhibits a strong neonatal healthcare system backed by government support and public health campaigns. Investments in modern technologies and nationwide programs emphasizing maternal and child health ensure that phototherapy treatments remain accessible and effective across the country.

India

India represents one of the fastest-growing markets due to its high birth rate and increasing awareness of neonatal jaundice. While urban healthcare facilities are well-equipped, rural areas still face significant challenges. Efforts to bridge this gap are gaining momentum.

In January 2024, Amrita Hospital, Faridabad, introduced India's first Mother-Neonatal Intensive Care Unit (M-NICU). Its emphasis on “zero separation from birth” aligns with WHO recommendations and represents a major step in improving neonatal outcomes.

Saudi Arabia

Saudi Arabia’s market growth is driven by increased healthcare spending, rising awareness of neonatal health, and large-scale adoption of modern medical technologies. Government initiatives targeting early diagnosis and advanced neonatal treatments are expected to further propel market expansion.

Market Segmentation Overview

Light Source

Fluorescent Lamps

LED Devices

Quartz Halogen Lamps

Gas Discharge Tubes

Configuration

Mobile Devices

Fixed Devices

End Users

Hospitals

Neonatal Clinics

Countries Covered

25 nations across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Key Players in the Infant Phototherapy Device Market

Ningbo David Medical Device Co.

Koninklijke Philips N.V.

General Electric Company

Inspiration Healthcare Group Plc

Drägerwerk AG & Co. KGaA

Ibis Medical Equipment & Systems Pvt. Ltd.

Weyer GmbH

Natus Medical Incorporated

These companies focus on product innovation, quality improvement, and expanded global reach to maintain competitive positions in an evolving market.

Final Thoughts

The infant phototherapy device market reflects a broader global commitment to improving neonatal health and reducing preventable infant deaths. With rising cases of neonatal jaundice and growing healthcare awareness, demand for advanced, efficient, and affordable phototherapy systems continues to climb worldwide.

While the market faces challenges such as unequal access and the high cost of advanced devices, ongoing innovations—including portable systems, LED-based units, and government initiatives—are steadily bridging those gaps. As healthcare infrastructures grow stronger and awareness improves, the next decade is set to reshape how neonatal jaundice is treated, ensuring safer beginnings for millions of newborns.